Control Blood Sugar Level with Insulin Delivery Device

To reduce the number of needle sticks, pumps provide an uninterrupted supply of insulin. Children or anybody who has problems remembering their insulin shots may consider them as well. Some people find insulin pumps to be more comfortable than insulin pen injections since they remain affixed to the body. Therefore, the global insulin delivery devices market is on track to hit $39,371.8 million in 2030.

North America is contributing more than 40% of revenue to the insulin delivery devices market. The regional market is expanding primarily as a result of the rising prevalence of lifestyle disorders such as diabetes and obesity, increasing public awareness of newer, more sophisticated diabetic treatment techniques, and growing healthcare spending. Additionally, the region has seen a significant increase in diabetes cases as a result of the region’s expanding obese population.

There Are Three Types of Insulin Delivery Devices

  • Insulin Pen: – Accurate dosage is one of the main benefits of insulin pens. Another benefit of using pens over syringes is that they are simpler to use. Pens don’t require as much manual dexterity or coordination, and they could be simpler for those with limited eyesight to use.
  • Insulin Syringe: – When using a syringe to administer insulin, the user first pushes air into the vial of the medication, inserts the needle into the vial, pulls back on the plunger until the appropriate dose is drawn into the barrel, inserts the needle in the skin, and later the plunger is pressed down till the barrel is empty.
  • Insulin Pump: – To reduce the number of needle sticks, pumps provide an uninterrupted supply of insulin. Children or anybody who has problems remembering their insulin shots may consider them as well. Some people find insulin pumps to be more comfortable than insulin pen injections since they remain affixed to the body.

Furthermore, insulin pens are predicted to have the fastest growth in the insulin delivery devices market, with a CAGR of over 10%. This can be due to the rise in diabetes prevalence and the increased focus of insulin pen producers on expanding their presence in nations with high rates of diabetes patients, such as China and India. The market for this category is also expanding as a result of medical reimbursements provided in developed nations and technical developments in pens.

Hence, Cases of diabetes are increasing each year all around the world, therefore the sale of insulin delivery devices is in high demand and it is expected that this demand will rise more in the coming years.

 

Comments are closed